Access & Availability
Australia Naltrexone PBS Check: Item 8370M and 2026 Co-payments
PBS item 8370M covers naltrexone 50 mg tablets; 2026 maximum co-payments are $25 general and $7.70 concession.
2 minute read
Category
Access & Availability articles
Current country-specific checks of product registration, funding, costs, and practical access routes.
Access & Availability
New Zealand Naltrexone Funding: June 2026 PHARMAC Check
Naltraccord 50 mg is fully subsidised under SA1408, while pharmacy charges and GP fees remain separate.
2 minute read
Access & Availability
Singapore Naltrexone Check: Contrave Is Registered—What About 50 mg?
Singapore's official formulary confirms Contrave, while current standalone 50 mg naltrexone supply and price remain unverified.
2 minute read
Access & Availability
UAE Naltrexone Registry Check: What Is Actually Listed?
A dated check of the UAE drug directory: Contrave is active, standalone naltrexone was not found, and DHA guidance still recognises naltrexone clinically.
2 minute read